glp 1 with alcohol A preliminary study of the physiological and perceptual effects of GLP-1 receptor agonists during consumption in people obesity Characterizing ghrelin's role in dysregulating

Some researchers suspect that reducing GLP-1 medication dosage through a slow, sustained taper (instead of rapidly decreasing dosage over a short period of time, or stopping them suddenly altogether), could help some patients prevent rebound weight gain, but well need more data to confirm this with any confidence or say why it might be the case

PMID: 10337905

we compare NAD, NMN, and NR, different routes of administration, their safety, and bioavailability

So blood glucose was less, where if you took it intravenously, it would spike and stay up

NHS and NICE Guidance on Weight Loss Treatments The National Institute for Health and Care Excellence (NICE) provides comprehensive, evidence-based guidance on weight management interventions for adults